Elizabeth Armstrong - Comment

Document ID: FDA-2011-N-0921-0043
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 04 2013, at 12:00 AM Eastern Standard Time
Date Posted: March 13 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: January 31 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: May 16 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-840l-ry2x
View Document:  View as format xml

View Comment

The uploaded file is testimony delivered at the FDA public hearing on February 28.

Attachments:

Elizabeth Armstrong Comment

Title:
Elizabeth Armstrong Comment

View Attachment:

Related Comments

    View All
Total: 12
Nancy P (CSULA) - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2011-N-0921-0038

May 16,2013 11:59 PM ET
Sandra L. Largaespada - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2011-N-0921-0036

May 16,2013 11:59 PM ET
Sandra L. Largaespada - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2011-N-0921-0037

May 16,2013 11:59 PM ET
Elizabeth Armstrong - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2011-N-0921-0043

May 16,2013 11:59 PM ET
Tom P. Honigford - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2011-N-0921-0039

May 16,2013 11:59 PM ET